Purple Biotech Reaches Recommended Phase 2 Dose for NT219
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St headed for weekly gains as earnings season nears
- Oil falls as Trump comments on Iran talks ease supply fears
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: PPBT) | Delayed: 1.39 -0.05 (3.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.44 | 52 Week High | $ | |||
| Open | $1.42 | 52 Week Low | $ | |||
| Day High | $1.44 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 16,030 | |||||
| (NASDAQ: PPBT) | Delayed: 1.39 -0.05 (3.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.44 | 52 Week High | $ | |||
| Open | $1.42 | 52 Week Low | $ | |||
| Day High | $1.44 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 16,030 | |||||
